Article Type

1 - 15 of 69 Results       Clear All

Can CRISPR-Based COVID-19 Testing Using Smartphones Slow the Pandemic?

Gladstone in the News December 13, 2020

Can CRISPR-Based COVID-19 Testing Using Smartphones Slow the Pandemic?

Forbes—In an article about the need for rapid testing to monitor and curb the COVID-19 pandemic, Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, explains the advantages of the CRISPR- and smartphone-based detection platform she developed with Senior Investigator and Nobel Laureate Jennifer Doudna, PhD, and UC Berkeley Professor Dan Fletcher, PhD.

Gladstone Experts COVID-19 Data Science and Biotechnology Virology Doudna Lab Ott Lab

COVID Test May Be as Close as Your Smartphone, Say UC, Gladstone Researchers

Gladstone in the News December 11, 2020

COVID Test May Be as Close as Your Smartphone, Say UC, Gladstone Researchers

San Francisco Business Times—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, discusses the rapid, smartphone-based Coronavirus detection assay her group recently described in the scientific publication Cell. The assay was developed by Graduate Student Parinaz Fozouni, in collaboration with the labs of Senior Scientist and Nobel Laureate Jennifer Doudna, PhD, and of UC Berkeley Bioengineering Professor Dan Fletcher, PhD.

Gladstone Experts COVID-19 Data Science and Biotechnology Virology Doudna Lab Ott Lab

Fast, Cheap, Accurate: Researchers Pin Hopes on Nobel Prize–Winning CRISPR Technology to Detect Coronavirus

Gladstone in the News October 28, 2020

Fast, Cheap, Accurate: Researchers Pin Hopes on Nobel Prize–Winning CRISPR Technology to Detect Coronavirus

USA Today—Senior Investigator and Nobel Laureate Jennifer Doudna, PhD, shares her view of CRISPR-based coronavirus detection kits and the possibility they might be deployed during the current pandemic. She and Senior Investigator Melanie Ott, MD, PhD, recently described the test they developed together in a publication posted on the electronic preprint platform bioRxiv.

Gladstone Experts COVID-19 Data Science and Biotechnology Virology Doudna Lab Ott Lab CRISPR/Gene Editing

Doudna Inc.: How Cal Scientist Created a Biotech Startup Engine

Gladstone in the News October 6, 2020

Doudna Inc.: How Cal Scientist Created a Biotech Startup Engine

San Francisco Business Times—As Scribe Therapeutics Inc., the latest company founded by Senior Investigator Jennifer Doudna, PhD, announced that it landed a deal with Biogen Inc., Gladstone President Deepak Srivastava, MD, commented on the importance of CRISPR-based biotech companies for medicine and agriculture and on Doudna’s drive as a scientist.

Gladstone Experts Cardiovascular Disease Data Science and Biotechnology Doudna Lab Srivastava Lab CRISPR/Gene Editing

CRISPR Screening Identifies Human Host Pathways That Facilitate Coronavirus Infection

Gladstone in the News September 27, 2020

CRISPR Screening Identifies Human Host Pathways That Facilitate Coronavirus Infection

Life Sciences—The online science news hub Life Sciences highlights recent work from Senior Investigators Melanie Ott, MD, PhD, and Nevan Krogan, PhD, and their colleagues at BioHub and Synthego Corporation. The work describes the identification of host factors common to three coronaviruses including SARS-CoV-2, and could help bootstrap efforts to stem current and future coronavirus epidemics.

Gladstone Experts COVID-19 Data Science and Biotechnology Virology Krogan Lab Ott Lab CRISPR/Gene Editing

Some Covid-19 Patients Show Signs of Heart Damage Months Later

Gladstone in the News September 23, 2020

Some Covid-19 Patients Show Signs of Heart Damage Months Later

The Wall Street Journal—Senior Investigator Todd McDevitt, PHD, comments on the damage SARS-CoV-2 can inflict on heart cells, which he and Senior Investigator Bruce Conklin, MD, recently reported in an article deposited on bioRxiv.

Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Conklin Lab McDevitt Lab

If You’ve Just Had COVID, Exercise Might Not Be Good for You

Gladstone in the News September 15, 2020

If You’ve Just Had COVID, Exercise Might Not Be Good for You

Wired—In an article about the potential dangers of strenuous exercise for people who have been infected with SARS-CoV-2, Senior Investigator Bruce Conklin, MD, is quoted for likening to "carnage" the damage the virus can inflict on heart cells. Conklin and Senior Investigator Todd McDevitt, PhD, recently reported their observations of cardiac cells from deceased COVID-19 patients or grown in the lab in BioRxiv.

Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Conklin Lab McDevitt Lab

Are You a Journalist Looking to Write about Gladstone?

Explore Info for Media